Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials

    Journal of the American Geriatrics Society Date published:

  • The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

    Kidney International Date published:

  • Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR

    Kidney International Reports Date published:

  • Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial

    Nephrology Dialysis Transplantation Date published:

  • Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

    New England Journal of Medicine Date published:

  • Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

    Kidney International Reports Date published:

  • Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials

    European Journal of Heart Failure Date published:

  • Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials

    Clinical Kidney Journal Date published:

  • Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD

    Kidney International Reports Date published:

  • Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials

    The Lancet Diabetes & Endocrinology Date published:

  • The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design

    JAMA Network Open Date published:

  • Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis

    Circulation Date published:

  • Semaglutide for Chronic Kidney Disease in Type 2 Diabetes

    New England Journal of Medicine Date published:

  • Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes

    Journal of the American College of Cardiology Date published:

  • Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy

    Kidney International Reports Date published: